HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/3/H1097    most recent 00650.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Alpert, N. R. Articles by Fananapazir, L. Search for Related Content PubMed PubMed Citation Articles by Alpert, N. R. Articles by Fananapazir, L.

Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations

¹Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, Vermont; ²Cardiovascular Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland; and ³Dakota Cardiovascular, Physician Corporation, Rapid City, South Dakota

Submitted 30 June 2004 ; accepted in final form 28 October 2004

Autosomal dominant familial hypertrophic cardiomyopathy (FHC) has variable penetrance and phenotype. Heterozygous mutations in MYH7 encoding -myosin heavy chain are the most common causes of FHC, and we proposed that "enhanced" mutant actin-myosin function is the causative molecular abnormality. We have studied individuals from families in which members have two, one, or no mutant MYH7 alleles to examine for dose effects. In one family, a member homozygous for Lys207Gln had cardiomyopathy complicated by left ventricular dilatation, systolic impairment, atrial fibrillation, and defibrillator interventions. Only one of five heterozygous relatives had FHC. Leu908Val and Asp906Gly mutations were detected in a second family in which penetrance for Leu908Val heterozygotes was 46% (21/46) and 25% (3/12) for Asp906Gly. Despite the low penetrance, hypertrophy was severe in several heterozygotes. Two individuals with both mutations developed severe FHC. The velocities of actin translocation (V_actin) by mutant and wild-type (WT) myosins were compared in the in vitro motility assay. Compared with WT/WT, V_actin was 34% faster for WT/D906G and 21% for WT/L908V. Surprisingly V_actin for Leu908Val/Asp906Gly and Lys207Gln/Lys207Gln mutants were similar to WT. The apparent enhancement of mechanical performance with mutant/WT myosin was not observed for mutant/mutant myosin. This suggests that V_actin may be a poor predictor of disease penetrance or severity and that power production may be more appropriate, or that the limited availability of double mutant patients prohibits any definitive conclusions. Finally, severe FHC in heterozygous individuals can occur despite very low penetrance, suggesting these mutations alone are insufficient to cause FHC and that uncharacterized modifying mechanisms exert powerful influences.

hypertrophy; cardiomyopathy; motility assay; penetrance

This article has been cited by other articles:

				J. P. Kaski, P. Syrris, M. T. T. Esteban, S. Jenkins, A. Pantazis, J. E. Deanfield, W. J. McKenna, and P. M. Elliott Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy Circ Cardiovasc Genet, October 1, 2009; 2(5): 436 - 441. [Abstract] [Full Text] [PDF]

				M. Kelly and C. Semsarian Multiple Mutations in Genetic Cardiovascular Disease: A Marker of Disease Severity? Circ Cardiovasc Genet, April 1, 2009; 2(2): 182 - 190. [Full Text] [PDF]

				D. Hilfiker-Kleiner and R. Knoll Disease-Modifying Mutations in Familial Hypertrophic Cardiomyopathy: Complexity From Simplicity Circulation, April 8, 2008; 117(14): 1775 - 1777. [Full Text] [PDF]

				E. P. Debold, J. P. Schmitt, J. B. Patlak, S. E. Beck, J. R. Moore, J. G. Seidman, C. Seidman, and D. M. Warshaw Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse {alpha}-cardiac myosin in the laser trap assay Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H284 - H291. [Abstract] [Full Text] [PDF]

				G Norbury and C J Norbury DNA analysis: what and when to request? Arch. Dis. Child., April 1, 2006; 91(4): 357 - 360. [Abstract] [Full Text] [PDF]